Quest Partners LLC bought a new position in Limbach Holdings, Inc. (NASDAQ:LMB – Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 2,731 shares of the construction company’s stock, valued at approximately $207,000.
Other large investors have also made changes to their positions in the company. American Capital Advisory LLC bought a new stake in shares of Limbach in the 3rd quarter worth about $25,000. nVerses Capital LLC bought a new stake in shares of Limbach in the 3rd quarter worth about $53,000. Harbor Capital Advisors Inc. grew its holdings in shares of Limbach by 6.3% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 2,736 shares of the construction company’s stock worth $207,000 after purchasing an additional 162 shares during the last quarter. Mraz Amerine & Associates Inc. bought a new stake in Limbach during the 3rd quarter worth about $265,000. Finally, The Manufacturers Life Insurance Company bought a new stake in Limbach during the 2nd quarter worth about $223,000. Institutional investors own 55.85% of the company’s stock.
Wall Street Analyst Weigh In
A number of brokerages have commented on LMB. Roth Mkm increased their price objective on shares of Limbach from $67.00 to $80.00 and gave the stock a “buy” rating in a report on Monday, November 4th. Stifel Nicolaus began coverage on shares of Limbach in a report on Friday, November 15th. They set a “buy” rating and a $108.00 price objective on the stock. Finally, StockNews.com lowered shares of Limbach from a “buy” rating to a “hold” rating in a report on Thursday, November 14th.
Limbach Stock Performance
Limbach stock opened at $98.76 on Thursday. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.14. Limbach Holdings, Inc. has a 1 year low of $35.24 and a 1 year high of $104.98. The company has a market cap of $1.11 billion, a PE ratio of 46.38, a PEG ratio of 3.37 and a beta of 0.97. The company’s 50-day moving average is $83.52 and its two-hundred day moving average is $67.80.
Limbach (NASDAQ:LMB – Get Free Report) last released its earnings results on Tuesday, November 5th. The construction company reported $0.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.57 by $0.05. Limbach had a net margin of 5.08% and a return on equity of 20.16%. The company had revenue of $133.90 million for the quarter, compared to the consensus estimate of $129.50 million. During the same period in the prior year, the company posted $0.61 EPS. The company’s revenue was up 4.9% compared to the same quarter last year. Equities analysts anticipate that Limbach Holdings, Inc. will post 2.54 earnings per share for the current year.
Insider Buying and Selling at Limbach
In related news, Director Joshua Horowitz sold 5,000 shares of the stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $64.02, for a total value of $320,100.00. Following the sale, the director now directly owns 190,000 shares in the company, valued at $12,163,800. This trade represents a 2.56 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 10.20% of the company’s stock.
About Limbach
Limbach Holdings, Inc operates as a building systems solution company in the United States. It operates through two segments, General Contractor Relationships and Owner Direct Relationships. The company engages in the construction and renovation projects that involve primarily include mechanical, plumbing, and electrical services.
See Also
- Five stocks we like better than Limbach
- Market Cap Calculator: How to Calculate Market Cap
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Differences Between Momentum Investing and Long Term Investing
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding LMB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Limbach Holdings, Inc. (NASDAQ:LMB – Free Report).
Receive News & Ratings for Limbach Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Limbach and related companies with MarketBeat.com's FREE daily email newsletter.